References
- 1. Akman T. et al.: The Neuroprotective Effect of Glycyrrhizic Acid on an Experimental Model of Focal Cerebral Ischemia in Rats. Inflammation, 38, 1581, 2015.
- 2. Aly A.M., Al-Alousi L., Salem H.A.: Licorice: A Possible Anti-inflammatory and Anti-ulcer Drug AAPS PharmSciTech., 6, 74, 2005.
- 3. Ashfaq U.A. et al: Glycyrrhizin as antiviral agent against Hepatitis C Virus. J. Transl. Med., 9, 1, 2011.
- 4. Asl M.N., Hosseinzadeh H.: Review of Pharmacological Effects of Glycyrrhiza sp. and its Bioactive Compounds. Phytother. Res., 22, 709, 2008.
- 5. Baltina L.A. et al.: Search for new drugs prospects for the creation of new antiviral drugs based on glycyrrhizic acid and its derivatives (a review). Pharm. Chem. J., 43, 539, 2009.
- 6. Bhattacharjee S. et al.: Glycyrrhizic acid suppresses Cox-2-mediated anti-inflammatory responses during Leishmania donovani infection. J. Antimicrob. Chemother., 67, 1905, 2012.
- 7. Carmines E.L., Lemus R., Gaworski C.L.: Toxicologic evaluation of licorice extract as a cigarette ingredient. Food Chem. Toxicol., 43, 1303, 2005.
- 8. Fenwick G.R., Lutomski J., Nieman C.: Liquorice, Glycyrrhiza glabra L. Composition, Uses and Analysis. Food Chem., 38, 119, 1990.
- 9. Fiore C. et al.: A history of the therapeutic use of liquorice in Europe, J. Ethnopharmacol., 99, 317, 2005.
- 10. Fiore C. et al.: Antiviral Effects of Glycyrrhiza species. Phytother. Res., 22, 141, 2008.
- 11. Gupta P., Das P.K., Ukil A.: Antileishmanial Effect of 18β-Glycyrrhetinic Acid Is Mediated by Toll-Like Receptor-Dependent Canonical and Noncanonical p38 Activation Antimicrob. Agents Chemother., 59, 2531, 2015.
- 12. Harada S. et al.: Biochemical characterisation of recombinant HIV-1 reverse transcriptase (rRT) as a glycyrrhizin-binding protein and the CK-II-mediated stimulation of rRT activity potently inhibited by glycyrrhetenic acid derivate. Biol. Pharm. Bull., 21, 1282, 1998.
- 13. Hardy M.E. et al.: 18β-glycyrrhetinic acid inhibits rotavirus replication in culture. Virol. J., 9, 1, 2012.
- 14. Hu J., Wu J., Ju Y.: A dual-responsive macrocycle based on glycyrrhetinic acid. Tetrahedron Lett., 53, 6705, 2012.
- 15. Indena®. Industria Derivati Naturali. www.indena.com/pdf/18beta_18betaPhyto_st_pc.pdf (access: 2016.01.02).
- 16. Isbrucker R.A., Burdock G.A.: Risk and safety assessment on the consumption of Licorice root (Glycyrrhiza sp.), its extract and powder as a food ingredient, with emphasis on the pharmacology and toxicology of glycyrrhizin. Regul. Toxicol. Pharmacol., 46, 167, 2006.
- 17. Jeong H.G. et al.: Hepatoprotective effects of 18β-glycyrrhetinic acid on carbontetrachloride-induced liver injury: inhibition of cytochrome p450 2e1 expression. Pharmacol. Res., 46, 221, 2002.
- 18. Jiang L. et al.: Discovery of glycyrrhetinic acid as an orally active, direct inhibitor of blood coagulation factor xa. Thromb. Res., 133, 501, 2014.
- 19. Kalani K. et al.: Glycyrrhetinic acid and its analogs: A new class of antifilarial agents. Bioorg. Med. Chem. Lett., 23, 2566, 2013.
- 20. Kalani K. et al.: In Silico and In Vivo Anti-Malarial Studies of 18β Glycyrrhetinic Acid from Glycyrrhiza glabra. PLoS One, 8, 1, 2013.
- 21. Kang L. et al.: Research Progress on Structure Modification and Biological Activity of 18β-Glycyrrhetinic Acid, Curr. Opin. Complement. Alternat. Med., 1, 34, 2014.
- 22. Kao T.C., Wu C.H., Yen G.C.: Bioactivity and Potential Health Benefits of Licorice. J. Agric. Food Chem., 62, 543, 2014.
- 23. Kayser O., Kiderlen A.F., Croft S.L.: Natural products as antiparasitic drugs, Parasitol. Res., 90, S55, 2003.
- 24. Kim H.K. et al.: Antimicrobial mechanism of β-glycyrrhetinic acid isolated from licorice, Glycyrrhiza glabra Biotechnol. Lett., 24, 1899, 2002.
- 25. Krausse R. et al.: In vitro anti-Helicobacter pylori activity of Extractum liquiritiae, glycyrrhizin and its metabolites, J. Antimicrob. Chemother., 54, 243, 2004.
- 26. Kumada H.: Long-term treatment of chronic hepatitis C with glycyrrhizin [Stronger Neo-Minophagen C (SNMC)] for preventing liver cirrhosis and hepatocellular carcinoma, Oncology, 62, 94, 2002.
- 27. Lacaille-Dubois M.A., Wagner H.: A review of the biological and pharmacological activities of saponins, Phytomedicine, 2, 363, 1996.
- 28. Long D.R. et al.: 18β-Glycyrrhetinic Acid Inhibits Methicillin-Resistant Staphylococcus aureus Survival and Attenuates Virulence Gene Expression, Antimicrob. Agents Chemother., 57, 241, 2013.
- 29. Moon M.H. et al.: 18β-Glycyrrhetinic acid inhibits adipogenic differentiation and stimulates lipolysis, Biochem. Biophys. Res. Commun., 420, 805, 2012.
- 30. Nascimento G.G.F. et al.: Antibacterial activity of plant extracts and phytochemicals on antibiotic-resistant bacteria. Braz. J. Microbiol., 31, 247, 2000.
- 31. Nitalikar M.M. et al.: Studies of antibacterial activities of glycyrrhiza glabra root extract. Int. J. Pharm.Tech. Res., 2, 899, 2010.
- 32. Pellati D. et al.: In vitro Effects of Glycyrrhetinic Acid on the Growth of Clinical Isolates of Candida albicans. Phytother. Res., 23, 572, 2009.
- 33. Rodrigues I.A. et al.: Natural Products: Insights into Leishmaniasis. Inflammatory Response. Mediators Inflamm., 2015, 1, 2015.
- 34. Salari M.H., Eshraghi S., Noroozi M.: Antibacterial effects of glycyrrhetinic acid on 55 hospital strains of Staphylococcus aureus and 32 actinobacillus actinomycetemcomitans. DARU, 9, 37, 2001.
- 35. Salari M.H., Kadkhoda Z.: In vitro antibacterial effects of glycyrrhetinic acid on periodontopathogenic and capnophilic bacteria isolated from adult periodontitis. Clin. Microbiol. Infect., 9, 987, 2003.
- 36. Semalty A. et al.: Supramolecular phospholipids–polyphenolics interactions: The PHYTOSOME® strategy to improve the bioavailability of phytochemicals. Fitoterapia, 81, 306, 2010.
- 37. Smolarczyk R. et al.: The Role of Glycyrrhizin, an Inhibitor of HMGB1 Protein, in Anticancer Therapy. Arch. Immunol. Ther. Exp., 60, 391, 2012.
- 38. Sparg S.G., Light M.E., van Staden J.: Biological activities and distribution of plant saponins. J. Ethnopharmacol., 94, 219, 2004.
- 39. Stanetty C. et al.: Synthesis and antiviral activities of spacer-linked 1-thioglucuronide analogues of glycyrrhizin. Beilstein J. Org. Chem., 8, 705, 2012.
- 40. Tolstikov A., Baltina A., Serdyuk N.G.: Search for new drugs: Glycyrrhetic acid (a review). Pharm. Chem. J., 32, 5, 1998.
- 41. Tykarska E., Czarczyńska-Goslińska B., Lulek J.: Kwas glicyryzynowy i glicyretynowy w nowoczesnej technologii farmaceutycznej. Czas. Aptek., 19, 43, 2012.
- 42. Ukil A. et al.: Leishmaniasis Associated with the Activation Up-Regulation in Experimental Visceral Th1 Response and Nitric Oxide 18β-Glycyrrhetinic Acid Triggers Curative. J. Immunol., 175, 1161, 2005.
- 43. Ukil A. et al.: Curative Effect of 18b-Glycyrrhetinic Acid in Experimental Visceral Leishmaniasis Depends on Phosphatase-Dependent Modulation of Cellular MAP Kinases. PLoS One, 6, 1, 2011.
- 44. Vampa G., Benvenuti S.: Separtion of 18α- and 18β-glycyrrhetinic acid by high-performance thin-layer chromatographic densitometry. J. Chromatogr. A, 543, 479, 1991.
- 45. Van Rossum T.G. et al.: Glycyrrhizin induced reduction of ALT in Europea n patients with chronic hepatitis C. Am. J. Gastroenterol., 96, 2432, 2001.
- 46. Wang L.J. et al.: Synthesis, biological evaluation and structure–activity relationships of glycyrrhetinic acid derivatives as novel anti-hepatitis B virus agents. Bioorg. Med. Chem. Lett., 22, 3473, 2012.
- 47. Yamaguchi H. et al.: Novel effects of glycyrrhetinic acid on the central nervous system tumorigenic progenitor cells: Induction of actin disruption and tumor cell-selective toxicity. Eur. J. Med. Chem., 45, 2943, 2010.
- 48. Yeh C.F. et al.: Water extract of licorice had anti-viral activity against human respiratory syncytial virus in human respiratory tract cell lines. J. Ethnopharmacol., 148, 466, 2013.
- 49. Zhao C.H. et al.: Inhibition of human enterovirus 71 replication by pentacyclic triterpenes and their novel synthetic derivatives. Chem. Pharm. Bull., 62, 764, 2014.
- 50. Zhou J. et al. 18β-glycyrrhetinic acid suppresses experimental autoimmune encephalomyelitis through inhibition of microglia activation and promotion of remyelination. Sci. Rep., 5, 1, 2015.
- 51. Zhou X. et al.: Antimycobacterial and Synergistic Effects of 18β-Glycyrrhetinic Acid or Glycyrrhetinic acid-30-piperazine in Combination with Isoniazid, Rifampicin or Streptomycin against Mycobacterium bovis. Phytother. Res., 26, 253, 2012.